Cough Medicine Ambroxol Shows Promise in Slowing Parkinson's and Alzheimer's Progression
A phase 2 clinical trial suggests that ambroxol, an ingredient in cough medicines, may help stabilize neuropsychiatric symptoms and protect brain function in Parkinson's disease dementia, especially in genetically high-risk individuals, with further research needed to confirm its efficacy.